BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23846543)

  • 1. Opposite effects of typical and atypical anti-psychotic drugs on sensitized dopamine receptors: sub-chronic low dose Olanzapine exposure reverses sensitization but a similar regimen of low dose haloperidol potentiates sensitization effects.
    Dias FR; de Mello Bastos JM; de Fátima Dos Santos Sampaio M; Carey RJ; Carrera MP
    Psychopharmacology (Berl); 2013 Dec; 230(4):579-88. PubMed ID: 23846543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual dopamine receptor desensitization following either high- or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine.
    Dias FR; de Matos LW; Dos Santos Sampaio Mde F; Carey RJ; Carrera MP
    Psychopharmacology (Berl); 2013 Jan; 225(1):141-50. PubMed ID: 22825579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist.
    Dias FR; de Matos LW; Sampaio Mde F; Carey RJ; Carrera MP
    Behav Brain Res; 2012 Apr; 229(1):153-9. PubMed ID: 22244923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric studies of antipsychotic-induced sensitization in the conditioned avoidance response model: roles of number of drug exposure, drug dose, and test-retest interval.
    Swalve N; Li M
    Behav Pharmacol; 2012 Aug; 23(4):380-91. PubMed ID: 22732209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
    Li M; Sun T; Zhang C; Hu G
    Psychopharmacology (Berl); 2010 Sep; 212(1):45-57. PubMed ID: 20623111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-trial dopaminergic modulation of conditioned catalepsy: A single apomorphine induced increase/decrease in dopaminergic activation immediately following a conditioned catalepsy response can reverse/enhance a haloperidol conditioned and sensitized catalepsy response.
    Oliveira LR; Dias FRC; Santos BG; Silva JLL; Carey RJ; Carrera MP
    Behav Brain Res; 2016 Sep; 311():87-98. PubMed ID: 27173428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-drug conditioning between citalopram and haloperidol or olanzapine in a conditioned avoidance response model: implications for polypharmacy in schizophrenia.
    Sparkman NL; Li M
    Behav Pharmacol; 2012 Oct; 23(7):658-68. PubMed ID: 22903071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of the behavioral mechanisms of antipsychotic action using a drug-drug conditioning paradigm.
    Li M; He W; Mead A
    Behav Pharmacol; 2009 Mar; 20(2):184-94. PubMed ID: 19322074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine.
    Zhang C; Li M
    Behav Pharmacol; 2012 Feb; 23(1):66-79. PubMed ID: 22157143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brexpiprazole has a low risk of dopamine D
    Amada N; Akazawa H; Ohgi Y; Maeda K; Sugino H; Kurahashi N; Kikuchi T; Futamura T
    Neuropsychopharmacol Rep; 2019 Dec; 39(4):279-288. PubMed ID: 31487433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents.
    Ugale RR; Hirani K; Morelli M; Chopde CT
    Neuropsychopharmacology; 2004 Sep; 29(9):1597-609. PubMed ID: 15100702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia.
    Amato D; Stasi MA; Borsini F; Nencini P
    Psychopharmacology (Berl); 2008 Oct; 200(2):157-65. PubMed ID: 18597076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine-induced context-specific behavioural sensitization is prevented by the D1 antagonist SCH-23390 but potentiated and uncoupled from contextual cues by the D2 antagonist sulpiride.
    Dias FR; Carey RJ; Carrera MP
    Psychopharmacology (Berl); 2010 Apr; 209(2):137-51. PubMed ID: 20177884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine and olanzapine exhibit an intrinsic anxiolytic property in two conditioned fear paradigms: contrast with haloperidol and chlordiazepoxide.
    Mead A; Li M; Kapur S
    Pharmacol Biochem Behav; 2008 Oct; 90(4):551-62. PubMed ID: 18547622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-trial apomorphine at an autoreceptor dose level can eliminate apomorphine conditioning and sensitization: support for the critical role of dopamine in re-consolidation.
    Carrera MP; Carey RJ; Cruz Dias FR; Dos Santos Sampaio MF; de Matos LW
    Behav Brain Res; 2013 Jan; 236(1):244-250. PubMed ID: 22759753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
    Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of conditioned reward association by typical and atypical antipsychotics.
    Danna CL; Elmer GI
    Pharmacol Biochem Behav; 2010 Jul; 96(1):40-7. PubMed ID: 20416333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.